LCIS: 2% annual cancer risk, less than 1% with chemoprevention

Women with lobular carcinoma in situ (LCIS) showed a 2% annual risk of developing breast cancer, and women who chose chemoprevention reduced their annual cancer rate to less than 1%, in a...